RGC
Regencell Bioscience Holdings Limited
$7.67
-21.81%
2026-10-23
About Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Key Fundamentals
EPS (TTM)
$-0.01
ROE
-177.7%
Profit Margin
0.0%
Debt/Equity
31.68
Price/Book
3085.00
Beta
1.43
Market Cap
$3.05B
Avg Volume (10D)
101K
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$11.31
60D Low
$4.91
Avg Volume
249K
Latest Close
$7.67
Get breakout alerts for RGC
Sign up for Breakout Scanner to receive daily notifications when RGC triggers breakout signals. Build custom AI screeners and backtest strategies.
Create your account7-day free trial, no card needed. Then $20/month.
Regencell Bioscience Holdings Limited (RGC) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors RGC daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. RGC operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry. Data is provided for informational purposes only and does not constitute financial advice.